000			01906 a2200505 4500
005			20250513101605.0
264		0	_c19961209
008			199612s 0 0 eng d
022			_a0148-396X
024	7		_a10.1097/00006123-199603000-00035 _2doi
040			_aNLM _beng _cNLM
100	1		_aZhang, W
245	0	0	_aMalignant glioma sensitivity to radiotherapy, high-dose tamoxifen, and hypericin: corroborating clinical response in vitro: case report. _h[electronic resource]
260			_bNeurosurgery _cMar 1996
300			_a587-90; discussion 590-1 p. _bdigital
500			_aPublication Type: Case Reports; Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAdult
650	0	4	_aAnthracenes
650	0	4	_aAntineoplastic Agents _xadministration & dosage
650	0	4	_aAntineoplastic Agents, Hormonal _xadministration & dosage
650	0	4	_aBrain Neoplasms _xdrug therapy
650	0	4	_aCell Division _xdrug effects
650	0	4	_aChemotherapy, Adjuvant
650	0	4	_aCombined Modality Therapy
650	0	4	_aCranial Irradiation
650	0	4	_aCraniotomy
650	0	4	_aDominance, Cerebral _xphysiology
650	0	4	_aDose-Response Relationship, Drug
650	0	4	_aFemale
650	0	4	_aFrontal Lobe _xpathology
650	0	4	_aHumans
650	0	4	_aMagnetic Resonance Imaging
650	0	4	_aNeoplasm Recurrence, Local _xdrug therapy
650	0	4	_aNeoplasm, Residual _xdrug therapy
650	0	4	_aPerylene _xadministration & dosage
650	0	4	_aRadiotherapy, Adjuvant
650	0	4	_aReoperation
650	0	4	_aTamoxifen _xadministration & dosage
650	0	4	_aTumor Cells, Cultured _xdrug effects
700	1		_aHinton, D R
700	1		_aSurnock, A A
700	1		_aCouldwell, W T
773	0		_tNeurosurgery _gvol. 38 _gno. 3 _gp. 587-90; discussion 590-1
856	4	0	_uhttps://doi.org/10.1097/00006123-199603000-00035 _zAvailable from publisher's website
999			_c8832004 _d8832004